# Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer （Radiogenomics-Esophagus）

> **NCT07354295** · — · RECRUITING · sponsor: **Shu Peng** · enrollment: 1500 (estimated)

## Conditions studied

- Esophageal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07354295
- **Lead sponsor:** Shu Peng
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-26
- **Primary completion:** 2030-09-30
- **Final completion:** 2030-09-30
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2026-03-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07354295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07354295, "Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer （Radiogenomics-Esophagus）". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07354295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*